These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 9131009

  • 1. A comparison of the effects of ifosfamide vs. mafosfamide treatment on intracellular glutathione levels and immunological functions of immunocompetent lymphocyte subsets.
    Botzler C, Kis K, Issels R, Multhoff G.
    Exp Hematol; 1997 Apr; 25(4):338-44. PubMed ID: 9131009
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of ifosfamide on the capacity of cytotoxic T lymphocytes and natural killer cells to lyse their target cells correlate with intracellular glutathione levels.
    Multhoff G, Meier T, Botzler C, Wiesnet M, Allenbacher A, Wilmanns W, Issels RD.
    Blood; 1995 Apr 15; 85(8):2124-31. PubMed ID: 7718883
    [Abstract] [Full Text] [Related]

  • 3. Glutathione modulates activation-dependent proliferation of human peripheral blood lymphocyte populations without regulating their activated function.
    Smyth MJ.
    J Immunol; 1991 Mar 15; 146(6):1921-7. PubMed ID: 2005386
    [Abstract] [Full Text] [Related]

  • 4. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
    Condiotti R, Nagler A.
    Exp Hematol; 1998 Jul 15; 26(7):571-9. PubMed ID: 9657131
    [Abstract] [Full Text] [Related]

  • 5. Bacterial activation of human natural killer cells. Characteristics of the activation process and identification of the effector cell.
    Tarkkanen J, Saksela E, Lanier LL.
    J Immunol; 1986 Oct 15; 137(8):2428-33. PubMed ID: 3093576
    [Abstract] [Full Text] [Related]

  • 6. Regulation by glutathione of the effect of lymphokines on differentiation of primary activated lymphocytes. Influence of glutathione on cytotoxic activity of CD3-AK-.
    Liang SM, Liang CM, Hargrove ME, Ting CC.
    J Immunol; 1991 Mar 15; 146(6):1909-13. PubMed ID: 1826013
    [Abstract] [Full Text] [Related]

  • 7. Purine metabolites suppress proliferation of human NK cells through a lineage-specific purine receptor.
    Miller JS, Cervenka T, Lund J, Okazaki IJ, Moss J.
    J Immunol; 1999 Jun 15; 162(12):7376-82. PubMed ID: 10358189
    [Abstract] [Full Text] [Related]

  • 8. Effects of ifosfamide on immunocompetent effector cells.
    Multhoff G, Botzler C, Allenbacher A, Issels R.
    Cancer Immunol Immunother; 1996 May 15; 42(4):251-4. PubMed ID: 8665573
    [Abstract] [Full Text] [Related]

  • 9. Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells.
    Itoh K, Tilden AB, Kumagai K, Balch CM.
    J Immunol; 1985 Feb 15; 134(2):802-7. PubMed ID: 3917475
    [Abstract] [Full Text] [Related]

  • 10. Requirement of thiol compounds as reducing agents for IL-2-mediated induction of LAK activity and proliferation of human NK cells.
    Yamauchi A, Bloom ET.
    J Immunol; 1993 Nov 15; 151(10):5535-44. PubMed ID: 8228244
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation.
    Hamilos DL, Wedner HJ.
    J Immunol; 1985 Oct 15; 135(4):2740-7. PubMed ID: 4031498
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High-dose selection with mafosfamide results in sensitivity to DNA cross-linking agents: characterization of hypersensitive cell lines.
    Fritz G, Hengstler JG, Kaina B.
    Cancer Res; 1997 Feb 01; 57(3):454-60. PubMed ID: 9012473
    [Abstract] [Full Text] [Related]

  • 16. Abnormalities of peripheral blood T lymphocytes and natural killer cells in alcoholic hepatitis persist after a 3-month withdrawal period.
    Laso FJ, Madruga JI, López A, Ciudad J, Alvarez-Mon M, San Miguel J, Orfao A.
    Alcohol Clin Exp Res; 1997 Jun 01; 21(4):672-6. PubMed ID: 9194923
    [Abstract] [Full Text] [Related]

  • 17. Regulation by glutathione of the activation and differentiation of IL-4-dependent activated killer cells.
    Hargrove ME, Wang J, Ting CC.
    Cell Immunol; 1993 Jul 01; 149(2):433-43. PubMed ID: 8330319
    [Abstract] [Full Text] [Related]

  • 18. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
    Lin SJ, Kuo ML.
    Cytotherapy; 2008 Jul 01; 10(4):397-405. PubMed ID: 18574772
    [Abstract] [Full Text] [Related]

  • 19. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y, Steinherz P, Klingemann HG, Dennig D, Childs BH, McGuirk J, O'Reilly RJ.
    Clin Cancer Res; 1998 Nov 01; 4(11):2859-68. PubMed ID: 9829753
    [Abstract] [Full Text] [Related]

  • 20. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
    Fujimiya Y, Suzuki Y, Katakura R, Miyagi T, Yamaguchi T, Yoshimoto T, Ebina T.
    Clin Cancer Res; 1997 Apr 01; 3(4):633-43. PubMed ID: 9815731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.